PortfoliosLab logoPortfoliosLab logo
MGRX vs. CDE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MGRX vs. CDE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mangoceuticals Inc. Common Stock (MGRX) and Coeur Mining, Inc. (CDE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MGRX achieves a -51.32% return, which is significantly lower than CDE's -12.46% return.


MGRX

1D
-1.32%
1M
0.98%
6M
-54.11%
YTD
-51.32%
1Y
-76.46%
3Y*
-75.73%
5Y*
10Y*

CDE

1D
-2.44%
1M
-9.36%
6M
-27.78%
YTD
-12.46%
1Y
62.75%
3Y*
71.76%
5Y*
13.99%
10Y*
1.30%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MGRX vs. CDE - Yearly Performance Comparison


2026 (YTD)202520242023
MGRX
Mangoceuticals Inc. Common Stock
-51.32%-69.42%-41.74%-93.41%
CDE
Coeur Mining, Inc.
-12.46%211.71%75.46%0.62%

Correlation

The correlation between MGRX and CDE is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Mar 21, 2023

0.10

Fundamentals

Market Cap

MGRX:

$3.65M

CDE:

$10.15B

EPS

MGRX:

-$1.91

CDE:

$1.84

PS Ratio

MGRX:

12.76

CDE:

2.64

Total Revenue (TTM)

MGRX:

$304.81K

CDE:

$2.57B

Gross Profit (TTM)

MGRX:

$250.39K

CDE:

$909.07M

EBITDA (TTM)

MGRX:

-$18.03M

CDE:

$1.23B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MGRX vs. CDE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MGRX
MGRX Risk / Return Rank: 2626
Overall Rank
MGRX Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
MGRX Sortino Ratio Rank: 3838
Sortino Ratio Rank
MGRX Omega Ratio Rank: 3838
Omega Ratio Rank
MGRX Calmar Ratio Rank: 1212
Calmar Ratio Rank
MGRX Martin Ratio Rank: 1717
Martin Ratio Rank

CDE
CDE Risk / Return Rank: 7171
Overall Rank
CDE Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
CDE Sortino Ratio Rank: 7171
Sortino Ratio Rank
CDE Omega Ratio Rank: 7070
Omega Ratio Rank
CDE Calmar Ratio Rank: 7373
Calmar Ratio Rank
CDE Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MGRX vs. CDE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Mangoceuticals Inc. Common Stock (MGRX) and Coeur Mining, Inc. (CDE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MGRXCDEDifference
Sharpe ratioReturn per unit of total volatility

-1.29

Sortino ratioReturn per unit of downside risk

-1.36

Omega ratioGain probability vs. loss probability

1.02

1.19

-0.17

Calmar ratioReturn relative to maximum drawdown

-0.81

1.44

-2.25

Martin ratioReturn relative to average drawdown

-1.17

2.60

-3.77

MGRX vs. CDE - Sharpe Ratio Comparison

The current MGRX Sharpe Ratio is -0.41, which is lower than the CDE Sharpe Ratio of 0.87. The chart below compares the historical Sharpe Ratios of MGRX and CDE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MGRX vs. CDE - Drawdown Comparison

The maximum MGRX drawdown since its inception was -99.74%, roughly equal to the maximum CDE drawdown of -99.40%. Use the drawdown chart below to compare losses from any high point for MGRX and CDE.


Loading charts...

Drawdown Indicators


MGRXCDEDifference

Max Drawdown

Largest peak-to-trough decline

-99.74%

-99.40%

-0.34%

Max Drawdown (1Y)

Largest decline over 1 year

-94.09%

-43.80%

-50.29%

Max Drawdown (3Y)

Largest decline over 3 years

-99.36%

-43.80%

-55.56%

Max Drawdown (5Y)

Largest decline over 5 years

-75.31%

Max Drawdown (10Y)

Largest decline over 10 years

-87.42%

Current Drawdown

Current decline from peak

-99.43%

-94.59%

-4.84%

Average Drawdown

Average peak-to-trough decline

-90.65%

-81.52%

-9.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

65.34%

24.17%

+41.17%

Volatility

MGRX vs. CDE - Volatility Comparison

Mangoceuticals Inc. Common Stock (MGRX) has a higher volatility of 34.16% compared to Coeur Mining, Inc. (CDE) at 20.02%. This indicates that MGRX's price experiences larger fluctuations and is considered to be riskier than CDE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MGRXCDEDifference

Volatility (1M)

Calculated over the trailing 1-month period

34.16%

20.02%

+14.14%

Volatility (6M)

Calculated over the trailing 6-month period

147.51%

55.83%

+91.68%

Volatility (1Y)

Calculated over the trailing 1-year period

185.24%

72.44%

+112.80%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

162.64%

68.64%

+94.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

162.64%

68.86%

+93.78%

Dividends

MGRX vs. CDE - Dividend Comparison

MGRX has not paid dividends to shareholders, while CDE's dividend yield for the trailing twelve months is around 0.13%.


Financials

MGRX vs. CDE - Financials Comparison

This section allows you to compare key financial metrics between Mangoceuticals Inc. Common Stock and Coeur Mining, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00MOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
-56.85K
856.19M
(MGRX) Total Revenue
(CDE) Total Revenue
Values in USD except per share items

Frequently Asked Questions


MGRX and CDE have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MGRX has higher volatility (34.16%) compared to CDE (20.02%). In terms of maximum drawdown, MGRX dropped -99.74% vs CDE's -99.40%.

CDE currently has the higher Sharpe Ratio (0.87 vs -0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MGRX and CDE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer